Literature DB >> 23552572

High variation between hospitals in vena cava filter use for venous thromboembolism.

Richard H White1, Estella Marie Geraghty, Ann Brunson, Susan Murin, Ted Wun, Fred Spencer, Patrick S Romano.   

Abstract

BACKGROUND: The extent to which vena cava filter (VCF) use varies between hospitals in the management of acute venous thromboembolism (VTE) is not clear.
METHODS: We conducted a retrospective observational study that compared the frequency of VCF use among California hospitals from January 1, 2006, through December 31, 2010. Using administrative hospital discharge data, we followed explicit criteria to identify nontrauma patients with acute VTE, and determined the frequency of VCF placement in each of the hospitals that admitted more than 55 VTE patients. Multivariable hierarchical regression models to predict VCF use included important clinical and demographic variables as fixed effects and hospital as a random effect.
RESULTS: Among the 263 hospitals included, 130 643 acute VTE hospitalizations occurred with the placement of 19 537 VCFs (14.95%). Variation in the percentage of acute VTE hospitalizations that included VCF placement was very high, from 0% to 38.96% (interquartile range, 6.23%-18.14%), with 18.49% of the observed variation due to differences among the hospitals that provided care. Significant clinical predictors of VCF use included acute bleeding at the time of admission (odds ratio, 3.4 [95% CI, 3.2-3.6]), a major operation after admission for VTE (3.4 [3.3-3.5]), presence of metastatic cancer (1.7 [1.6-1.8]), and extreme severity of illness (2.5 [2.3-2.7] vs mild). Insertion of VCFs occurred more frequently than expected in 109 hospitals and less frequently in 59. Hospital characteristics associated with VCF use included a small number of beds (odds ratio, 0.2 [95% CI, 0.2-0.4], <100 vs >400 beds), a rural location (0.4 [0.2-0.5]), and other private vs Kaiser hospitals (1.5 [1.1-2.0]). Use of VCFs varied widely even in geographically proximate areas.
CONCLUSIONS: The frequency of VCF use in patients with acute VTE varied widely and depended on which hospital provided the care, even after adjusting for clinical and socioeconomic factors. Further research is needed to determine whether this variation is associated with local cultural differences between hospitals or with differences in the availability of interventional radiologists or specialists, or whether it reflects the absence of high-quality evidence that VCFs are effective.

Entities:  

Mesh:

Year:  2013        PMID: 23552572     DOI: 10.1001/jamainternmed.2013.2352

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  20 in total

Review 1.  Procedural and indwelling complications with inferior vena cava filters: frequency, etiology, and management.

Authors:  Lazar Milovanovic; Sean A Kennedy; Mehran Midia
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

2.  Device therapy: variation in the use of inferior vena cava filters for VTE.

Authors:  Sanjeeva P Kalva; Christos A Athanasoulis
Journal:  Nat Rev Cardiol       Date:  2013-04-30       Impact factor: 32.419

3.  Current practices in feeding tube placement for US acute ischemic stroke inpatients.

Authors:  Benjamin P George; Adam G Kelly; Eric B Schneider; Robert G Holloway
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

Review 4.  Inferior vena cava filter use and patient safety: legacy or science?

Authors:  William Geerts; Rita Selby
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Indications, applications, and outcomes of inferior vena cava filters for venous thromboembolism in Japanese patients.

Authors:  Yugo Yamashita; Takashi Unoki; Daisuke Takagi; Yasuhiro Hamatani; Mitsuru Ishii; Moritake Iguchi; Hisashi Ogawa; Nobutoyo Masunaga; Hiromichi Wada; Koji Hasegawa; Mitsuru Abe; Masaharu Akao
Journal:  Heart Vessels       Date:  2015-07-02       Impact factor: 2.037

6.  Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients.

Authors:  Lara Yoon; Grace Clarke Hillyer; Ling Chen; Jim C Hu; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Cancer Invest       Date:  2016-09-13       Impact factor: 2.176

7.  Variation in the Use of Vena Cava Filters for Venous Thromboembolism in Hospitals in Kentucky.

Authors:  Joshua D Brown; Jeffery C Talbert
Journal:  JAMA Surg       Date:  2016-10-01       Impact factor: 14.766

8.  Hospital Variation and Patient Characteristics Associated With Vena Cava Filter Utilization.

Authors:  Joshua D Brown; Jeffery C Talbert
Journal:  Med Care       Date:  2017-01       Impact factor: 2.983

9.  Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010.

Authors:  Behnood Bikdeli; Yun Wang; Karl E Minges; Nihar R Desai; Nancy Kim; Mayur M Desai; John A Spertus; Frederick A Masoudi; Brahmajee K Nallamothu; Samuel Z Goldhaber; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2016-03-08       Impact factor: 24.094

10.  California study of Ablation (CAABL):early utilization after index hospitalization for non-valvular atrial fibrillation.

Authors:  Uma Srivatsa; Beate Danielsen; Ezra Amsterdam; Yingbo Yang; Dali Fan; Nayereh Pezeshkian; Richard H White
Journal:  J Atr Fibrillation       Date:  2017-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.